SEC Form 4
Ocugen, Inc. (OCGN) insider trading
In the 12 months to Oct 23, 2026, one OCGN insider reported open-market sales of $1.1M across 2 filings; one chief financial officer bought $25.8K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $1.1M
- 2 filings · 1 insider
- Open-market purchases
- $25.8K
- 1 filing · Treerita Essalima Johnson-Greene, Chief Financial Officer
- Pre-arranged sales (10b5-1)
- 2 of 2
- All $1.1M sold was pre-arranged
Who traded OCGN, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
OCGN daily close from Oct 23, 2025 to Oct 23, 2026, between $0.74 and $2.48, last $0.74. 2 sale and 1 purchase filings by 2 insiders, marked at their filing dates. Shankar Musunuri, Chief Executive Officer: sold $1.1M across 2 filings, first filed Sep 11, 2026, last Oct 13, 2026. Treerita Essalima Johnson-Greene, Chief Financial Officer: bought $25.8K across 1 filing, first filed Jun 17, 2026, last Jun 17, 2026.
Largest mark · tap a row for others
Shankar Musunuri · Chief Executive Officer
Sale $589,110
525,991 shares at $1.12 avg
Filed Sep 11, 2026 · traded Sep 9
Pre-arranged (10b5-1) · close on filing date $1.02
Shankar Musunuri · Chief Executive Officer
Chief Executive Officer
$1.1M soldTreerita Essalima Johnson-Greene · Chief Financial Officer
Chief Financial Officer
$25.8K boughtHas Ocugen, Inc.'s CEO sold stock?
Yes. Shankar Musunuri (CEO) sold 1,051,982 shares ($1.1M) between Sep 2026 and Oct 2026, all under a pre-arranged 10b5-1 plan.
Open-market trades
3 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Shankar Musunuri | Chief Executive Officer | $1.1M | — | 2 | 100% of sales | |
| Treerita Essalima Johnson-Greene | Chief Financial Officer | — | $25.8K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Shankar Musunuri Chief Executive Officer | SalePre-arranged (10b5-1) | 525,991 | $0.95 | $499.7K | Multiple accounts | |
traded | Shankar Musunuri Chief Executive Officer | SalePre-arranged (10b5-1) | 525,991 | $1.12 | $589.1K | Multiple accounts | |
traded | Treerita Essalima Johnson-Greene Chief Financial Officer | Purchase | 21,000 | $1.23 | $25.8K | 521,000 |
GET /stocks/filings/vX/form-4?tickers=OCGN&filing_date.gte=2025-10-23&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"OCGN"
],
"issuer_cik": "0001372299",
"owner_cik": "0001791820",
"accession_number": "0001628280-26-065797",
"form_type": "4",
"filing_date": "2026-10-13",
"period_of_report": "2026-10-09",
"issuer_name": "Ocugen, Inc.",
"issuer_trading_symbol": "OCGN",
"owner_name": "Musunuri Shankar",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-09",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 57264,
"transaction_price_per_share": 0.95,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1030771,
"transaction_value": 54400.799999999996,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By: KVM Holdings, LLC",
"footnotes": [
{
"id": "F1",
"description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026"
},
{
"id": "F3",
"description": "The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (3) to this Form 4."
},
{
"id": "F4",
"description": "The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC."
}
]
},
{
"tickers": [
"OCGN"
],
"issuer_cik": "0001372299",
"owner_cik": "0001791820",
"accession_number": "0001628280-26-065797",
"form_type": "4",
"filing_date": "2026-10-13",
"period_of_report": "2026-10-09",
"issuer_name": "Ocugen, Inc.",
"issuer_trading_symbol": "OCGN",
"owner_name": "Musunuri Shankar",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-09",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 468727,
"transaction_price_per_share": 0.95,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 4018470,
"transaction_value": 445290.64999999997,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026"
},
{
"id": "F2",
"description": "The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to\nprovide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (2) to this Form 4."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 5 records
- Option exercises3 records
- Grants and awards2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for OCGN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.